Drug firm Unichem Laboratories today reported nearly 10-fold jump in standalone net profit to Rs 20.54 crore for the quarter ended December 31, mainly on account of robust sales.
The company had posted a profit of Rs 2.06 crore for the October-December quarter of the previous fiscal, 2014-15, Unichem Laboratories said in a filing to BSE.
Standalone total income from operations of the company also rose to Rs 306.26 crore for the third quarter of 2015-16 as against Rs 265.85 crore in the year-ago period.
Apart from the formulations, Unichem Laboratories also manufactures active pharmaceutical ingredients (APIs or bulk actives).
